The top 20 companies in terms of number of sponsored events
| Company | Number of events | Number of attendees | Total cost of food and beverage ($A) | Total cost of function* ($A) | Median total cost per event (IQR) ($A) |
| AstraZeneca | 13 968 | 435 686 | 12 725 027 | 31 766 776 | 318 (165–2261) |
| Novartis | 10 120 | 244 069 | 6 600 503 | 27 467 246 | 270 (167–1154) |
| Merck Sharp & Dohme | 9142 | 214 621 | 5 388 247 | 18 352 116 | 341 (180–1182) |
| Roche | 7383 | 174 878 | 2 891 426 | 16 625 126 | 186 (129–284) |
| Pfizer | 7125 | 188 439 | 3 740 677 | 18 464 785 | 236 (141–573) |
| Sanofi | 6764 | 261 089 | 3 243 420 | 13 668 127 | 240 (149–600) |
| Amgen | 5562 | 117 767 | 4 545 874 | 11 145 245 | 192 (117–332) |
| Eli Lilly | 5419 | 138 765 | 2 270 896 | 7 949 786 | 145 (62–455) |
| Servier Lab | 4245 | 145 111 | 4 347 268 | 14 002 283 | 482 (196–2252) |
| Mundipharma | 4168 | 135 517 | 2 956 613 | 8 939 046 | 342 (182–2394) |
| Janssen | 3901 | 140 549 | 3 168 024 | 14 643 568 | 320 (164–1818) |
| GlaxoSmithKline | 3706 | 103 331 | 2 993 037 | 6 292 242 | 254 (161–1645) |
| CSL | 3285 | 138 170 | 1 337 909 | 6 000 501 | 288 (179–1427) |
| Bristol Myers Squibb | 3151 | 138 446 | 2 492 290 | 12 755 630 | 245 (82–1900) |
| Bayer | 2964 | 151 084 | 1 417 055 | 8 146 292 | 396 (194–1500) |
| IPSEN | 2802 | 85 475 | 984 477 | 5 163 600 | 254 (169–454) |
| Abbott/AbbVie | 2774 | 59 793 | 3 291 305 | 6 437 623 | 255 (157–1037) |
| Boehringer Ingelheim | 2223 | 56 204 | 6 050 143 | 8 724 933 | 2007 (1308–2654) |
| Gilead Sciences | 2049 | 45 510 | 990 419 | 7 061 338 | 245 (160–540) |
| Merck Serono | 1841 | 41 809 | 1 376 023 | 4 237 372 | 229 (145–626) |
| Total – Top 20 | 102 592 | 3 016 313 | 72 810 634 | 247 843 635 | 262 (152–1199) |
| All companies | 116 845 | 3 481 750 | 84 862 792 | 286 117 928 | 263 (153–1195) |
*Includes food and drink, as well as other costs (eg, venue hire, speaker honoraria, audiovisual hire).